Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial

Follath, F; Cleland, JGF; Just, H; Papp, JGY; Scholz, H; Peuhkurinen, K; Harjola, VP; Mitrovic, V; Abdalla, M; Sandell, EP; +1 more... Lehtonen, L; (2002) Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet, 360 (9328). pp. 196-202. ISSN 0140-6736 DOI: https://doi.org/10.1016/S0140-6736(02)09455-2

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/S0140-6736(02)09455-2

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar